Literature DB >> 14675610

Ischemic stroke after using over the counter products containing ephedra.

Cassandra Chen1, Jose Biller, Steven J Willing, Alfredo M Lopez.   

Abstract

Dietary supplements containing Ephedra used for weight loss and physical performance enhancement such as "herbal ecstasy" are widely available, and it is estimated that at least 1% of the adult population have taken these products. Ephedra products including Ephedra alkaloids such as phenylpropanolamine or other ephedrine compounds are sold under different names such as Metabolife 356, Ripped Fuel, Thermadrene, and Shape-Fast Plus. Over 2 years, five patients with ischemic infarctions associated with use of Ephedra products were evaluated at Indiana University Hospital. Ephedrine, like other sympathomimetic agents, predisposes patients to both ischemic and hemorrhagic strokes. People who take over the counter Ephedra products that claim to boost weight loss, increase energy, or bolster physical performance are at risk of adverse events including ischemic and hemorrhagic strokes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14675610     DOI: 10.1016/j.jns.2003.08.012

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Combined Effects of Ephedrine-Containing Dietary Supplements, Caffeine, and Nicotine on Morphology and Ultrastructure of Rat Hearts.

Authors:  Christopher E Brown; Stanley E Trauth; Richard S Grippo; Bill J Gurley; Anne A Grippo
Journal:  J Caffeine Res       Date:  2012-09

2.  Ephedra use in a select group of adolescent athletes.

Authors:  Michael P Schaefer; Jay Smith; Diane L Dahm; Matthew C Sorenson
Journal:  J Sports Sci Med       Date:  2006-09-01       Impact factor: 2.988

Review 3.  Safety of drug therapies used for weight loss and treatment of obesity.

Authors:  Lisa L Ioannides-Demos; Joseph Proietto; Andrew M Tonkin; John J McNeil
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Hemorrhagic primary CNS angiitis and vasoconstrictive drug exposure.

Authors:  Mehmet A Topcuoglu; Ruchira M Jha; Jacob George; Matthew P Frosch; Aneesh B Singhal
Journal:  Neurol Clin Pract       Date:  2017-02

5.  Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects.

Authors:  C Csajka; C A Haller; N L Benowitz; D Verotta
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335

6.  Ephedra-Induced Gastric Mucosal Injury.

Authors:  Joseph B Lillegard; John R Porterfield
Journal:  Case Rep Gastroenterol       Date:  2010-02-27

7.  Neuroprotective effect of gui zhi (ramulus cinnamomi) on ma huang- (herb ephedra-) induced toxicity in rats treated with a ma huang-gui zhi herb pair.

Authors:  Fang-Hao Zheng; Ping Wei; Hui-Ling Huo; Xue-Feng Xing; Fei-Long Chen; Xiao-Mei Tan; Jia-Bo Luo
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-26       Impact factor: 2.629

8.  Methylephedrine-induced heart failure in a habitual user of paediatric cough syrup: a case report.

Authors:  Moeko Suzuki; Haruhiko Higashi; Shuntaro Ikeda; Osamu Yamaguchi
Journal:  Eur Heart J Case Rep       Date:  2020-04-27

9.  A case of ischemic colitis associated with the herbal food supplement ma huang.

Authors:  Hyun Joo Song; Ki-Nam Shim; Kum Hei Ryu; Tae Hun Kim; Sung-Ae Jung; Kwon Yoo
Journal:  Yonsei Med J       Date:  2008-06-30       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.